Metraipolis › archive › dc_edeb167f84f8

Impact of valproate co-medication and age on lurasidone exposure: a population pharmacokinetic study and real-world evaluation in Chinese psychiatric inpatients — Europe PMC PMID:42206172

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42206172
DOI
10.3389/fphar.2026.1810528
License (as archived)
solo-consultazione
Archived
2026-11-02T09:19:22.699Z
SHA-256 of the archived text
b7552653ceffe7405197549c7cb70df80aa7b16d788effc220f28d1be2db1579
Stable URL of this page
https://metraipolis.com/documento/dc_edeb167f84f8

How to cite

Impact of valproate co-medication and age on lurasidone exposure: a population pharmacokinetic study and real-world evaluation in Chinese psychiatric inpatients — Europe PMC PMID:42206172 — Europe PMC (en), https://europepmc.org/article/MED/42206172 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_edeb167f84f8 (Metraipolis archive dc_edeb167f84f8, sha256 b7552653ceffe7405197549c7cb70df80aa7b16d788effc220f28d1be2db1579)
BibTeX
@misc{dcedeb167f84f8,
  title = {Impact of valproate co-medication and age on lurasidone exposure: a population pharmacokinetic study and real-world evaluation in Chinese psychiatric inpatients — Europe PMC PMID:42206172},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42206172},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_edeb167f84f8; sha256 b7552653ceffe7405197549c7cb70df80aa7b16d788effc220f28d1be2db1579},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42206172. Agents can read the archived copy with the MCP tool read_document.